この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
規制と法律 · 2015/10/271 分で読めます
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler
ローカル自動翻訳 · 情報源の原言語
概要
The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma Solutions--New York, LLC. This over-the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.
情報源の原言語: Federal Register — Justice Department原文の発表を開く →